Evogene Ltd. (EVGN)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Agriculture	1.37M	2.96M	1.13M	876.00K	628.00K
Agriculture Growth	-53.50%	160.81%	29.34%	39.49%	-27.15%
Industrial Applications	2.17M	2.22M	1.08M	72.00K	40.00K
Industrial Applications Growth	-2.30%	106.42%	1393.06%	80.00%	21.21%
Human Health	-	80.00K	487.00K	513.00K	183.00K
Human Health Growth	-	-83.57%	-5.07%	180.33%	144.00%
Unallocated	311.00K	323.00K	287.00K	214.00K	79.00K
Unallocated Growth	-3.72%	12.54%	34.11%	170.89%	12.86%
Total	3.85M	5.58M	2.98M	1.68M	930.00K
Total Growth	-30.91%	87.02%	78.03%	80.11%	-10.58%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
United States	346.77K	948.09K	984.06K	854.25K	520.80K
United States Growth	-63.42%	-3.66%	15.20%	64.03%	-22.96%
Israel	462.36K	613.47K	924.42K	753.75K	353.40K
Israel Growth	-24.63%	-33.64%	22.64%	113.29%	54.46%
Europe	1.00M	2.29M	29.82K	-	-
Europe Growth	-56.19%	7567.91%	-	-	-
Africa	2.04M	1.73M	1.04M	-	-
Africa Growth	18.12%	65.65%	-	-	-
Other	-	-	-	67.00K	37.20K
Other Growth	-	-	-	80.11%	78.85%
Brazil	-	-	-	-	18.60K
Brazil Growth	-	-	-	-	-83.74%
Total	3.85M	5.58M	2.98M	1.68M	930.00K
Total Growth	-30.91%	87.02%	78.03%	80.11%	-10.58%

Source: S&P Global Market Intelligence.